Literature DB >> 27664894

Periadventitial adipose tissue modulates the effect of PROLI/NO on neointimal hyperplasia.

Edward S M Bahnson1, George E Havelka1, Nathaniel C Koo1, Qun Jiang1, Melina R Kibbe2.   

Abstract

BACKGROUND: Periadventitial delivery of nitric oxide (NO) inhibits neointimal hyperplasia; however, the effect of periadventitial adipose tissue on the efficacy of NO at inhibiting neointimal hyperplasia has not been studied. The aim of our study was to assess the effect of NO in the presence and absence of periadventitial adipose tissue. We hypothesized that removal of periadventitial adipose tissue will increase neointimal formation and that NO will be more effective at inhibiting neointimal hyperplasia.
METHODS: The effect of NO on 3T3 fibroblasts, adventitial fibroblast (AF), and vascular smooth muscle cell (VSMC) proliferation was assessed by (3)H-thymidine incorporation in adipocyte-conditioned or regular media. The rat carotid artery balloon injury model was performed on male Sprague-Dawley rats. Before balloon injury, periadventitial adipose tissue was removed (excised model) or remained intact (intact model). Treatment groups included injury or injury with periadventitial application of PROLI/NO. Adiponectin receptor (AR) levels were assessed via immunofluorescence.
RESULTS: Adipocyte-conditioned media had an antiproliferative effect on 3T3 and AF and a proproliferative effect on VSMC in vitro. Interestingly, NO was less effective at inhibiting 3T3 and AF proliferation and more effective at inhibiting VSMC proliferation in adipocyte-conditioned media. In vivo, the excised group showed increased neointimal hyperplasia 2 wk after surgery compared with the intact group. NO reduced neointimal hyperplasia to a greater extent in the excised group compared with the intact group. Although NO inhibited or had no impact on AR levels in the intact group, NO increased AR levels in media and adventitia of the excised group.
CONCLUSIONS: These data show that periadventitial adipose tissue plays a role in regulating the arterial injury response and the efficacy of NO treatment in the vasculature. Published by Elsevier Inc.

Entities:  

Keywords:  Adipokines; Neointimal hyperplasia; Nitric oxide; Periadventitial adipose tissue

Mesh:

Substances:

Year:  2016        PMID: 27664894      PMCID: PMC5081220          DOI: 10.1016/j.jss.2016.06.074

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  22 in total

Review 1.  Regulation of smooth muscle cell growth in injured artery.

Authors:  A W Clowes; M M Clowes; J Fingerle; M A Reidy
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

2.  Isopropylamine NONOate (IPA/NO) moderates neointimal hyperplasia following vascular injury.

Authors:  Nick D Tsihlis; Jozef Murar; Muneera R Kapadia; Sadaf S Ahanchi; Christopher S Oustwani; Joseph E Saavedra; Larry K Keefer; Melina R Kibbe
Journal:  J Vasc Surg       Date:  2010-03-11       Impact factor: 4.268

3.  Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor.

Authors:  V Lindner; M A Reidy
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

4.  Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries.

Authors:  Y Shi; J E O'Brien; A Fard; J D Mannion; D Wang; A Zalewski
Journal:  Circulation       Date:  1996-10-01       Impact factor: 29.690

5.  Periadventitial adipose tissue plays a critical role in vascular remodeling.

Authors:  Minoru Takaoka; Daisuke Nagata; Shinji Kihara; Iichiro Shimomura; Yu Kimura; Yasuhiko Tabata; Yoshihiko Saito; Ryozo Nagai; Masataka Sata
Journal:  Circ Res       Date:  2009-09-17       Impact factor: 17.367

6.  Mechanisms of arterial graft failure. II. Chronic endothelial and smooth muscle cell proliferation in healing polytetrafluoroethylene prostheses.

Authors:  A W Clowes; T R Kirkman; M M Clowes
Journal:  J Vasc Surg       Date:  1986-06       Impact factor: 4.268

7.  Beneficial effect of a short-acting NO donor for the prevention of neointimal hyperplasia.

Authors:  Charles G Pearce; Samer F Najjar; Muneera R Kapadia; Jozef Murar; Jason Eng; Brian Lyle; Oliver O Aalami; Qun Jiang; Joseph A Hrabie; Joseph E Saavedra; Larry K Keefer; Melina R Kibbe
Journal:  Free Radic Biol Med       Date:  2007-09-25       Impact factor: 7.376

8.  One-year costs in patients with a history of or at risk for atherothrombosis in the United States.

Authors:  Elizabeth M Mahoney; Kaijun Wang; David J Cohen; Alan T Hirsch; Mark J Alberts; Kim Eagle; Frederique Mosse; Joseph D Jackson; P Gabriel Steg; Deepak L Bhatt
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2008-09

9.  Vascular wall-resident CD44+ multipotent stem cells give rise to pericytes and smooth muscle cells and contribute to new vessel maturation.

Authors:  Diana Klein; Philip Weisshardt; Veronika Kleff; Holger Jastrow; Heinz Günther Jakob; Süleyman Ergün
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

10.  Hypoxia preconditioned mesenchymal stem cells prevent cardiac fibroblast activation and collagen production via leptin.

Authors:  Panpan Chen; Rongrong Wu; Wei Zhu; Zhi Jiang; Yinchuan Xu; Han Chen; Zhaocai Zhang; Huiqiang Chen; Ling Zhang; Hong Yu; Jian'an Wang; Xinyang Hu
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

View more
  1 in total

1.  Physalins V-IX, 16,24-cyclo-13,14-seco withanolides from Physalis angulata and their antiproliferative and anti-inflammatory activities.

Authors:  Cheng-Peng Sun; Chong-Yue Qiu; Feng Zhao; Ning Kang; Li-Xia Chen; Feng Qiu
Journal:  Sci Rep       Date:  2017-06-22       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.